Co-Diagnostics (CODX) $5 Million Registered Direct Offering of Common Stock

Go back to Co-Diagnostics (CODX) $5 Million Registered Direct Offering of Common Stock

Co-Diagnostics (CODX) Surges 180% after Designing Test for New Coronavirus

January 23, 2020 8:12 AM EST

Co-Diagnostics, Inc. (Nasdaq: CODX) shares are up 180% in pre-open trade after the company announced today that it has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the virus.

An outbreak of respiratory illness caused by the pneumonia-like 2019-nCoV has spread rapidly over the past two weeks, after first being discovered in the Chinese city of Wuhan on December 31.... More